{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:53:20Z","timestamp":1777949600520,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding and Beijing Hope Run Special Fund of Cancer Foundation of China","award":["LC2022A11"],"award-info":[{"award-number":["LC2022A11"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072837"],"award-info":[{"award-number":["82072837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15870-1","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:54:49Z","timestamp":1774436089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subtyping atypical eosinophilic renal cell tumours through integrated morphological, immunohistochemical, and mutational characters"],"prefix":"10.1186","volume":"26","author":[{"given":"Shan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tieliang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zitong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"15870_CR1","doi-asserted-by":"publisher","DOI":"10.1159\/000545812","author":"A Cimadamore","year":"2025","unstructured":"Cimadamore A, Franzese C, Heffernan JAJ, et al. Oncocytic Tumors in the Kidney: A Trifocal Review - Integrated Pathological, Cytopathological, and Molecular Perspectives (Part 1). Acta Cytol. 2025. https:\/\/doi.org\/10.1159\/000545812.","journal-title":"Acta Cytol"},{"key":"15870_CR2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.5858\/ARPA.2019-0203-RA","volume":"143","author":"KA Iczkowski","year":"2019","unstructured":"Iczkowski KA, Czaja RC. Eosinophilic Kidney Tumors: Old and New. Arch Pathol Lab Med. 2019;143:1455\u201363. https:\/\/doi.org\/10.5858\/ARPA.2019-0203-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"15870_CR3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/J.PATHOL.2022.09.002","volume":"54","author":"H Samaratunga","year":"2022","unstructured":"Samaratunga H, Egevad L, Thunders M, et al. LOT and HOT \u2026 or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia. Pathology. 2022;54:842\u20137. https:\/\/doi.org\/10.1016\/J.PATHOL.2022.09.002.","journal-title":"Pathology"},{"key":"15870_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MOU.0000000000001079","volume":"33","author":"A Oszwald","year":"2023","unstructured":"Oszwald A, Wasinger G, Zisser L, et al. Update on classification of oncocytic neoplasms of the kidney. Curr Opin Urol. 2023;33:239\u201344. https:\/\/doi.org\/10.1097\/MOU.0000000000001079.","journal-title":"Curr Opin Urol"},{"key":"15870_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/S00428-024-03909-2","volume":"485","author":"SK Mohanty","year":"2024","unstructured":"Mohanty SK, Lobo A, Jha S, et al. Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. Virchows Arch. 2024;485:829\u201340. https:\/\/doi.org\/10.1007\/S00428-024-03909-2.","journal-title":"Virchows Arch"},{"key":"15870_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/S41585-024-00897-5","volume":"22","author":"H Mansour","year":"2025","unstructured":"Mansour H, Tran-Dang MA, Walkden M, et al. Renal mass biopsy - a practical and clinicopathologically relevant approach to diagnosis. Nat Rev Urol. 2025;22:8\u201325. https:\/\/doi.org\/10.1038\/S41585-024-00897-5.","journal-title":"Nat Rev Urol"},{"key":"15870_CR7","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","volume":"41","author":"K Trpkov","year":"2017","unstructured":"Trpkov K, Abou-Ouf H, Hes O, et al. Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity. Am J Surg Pathol. 2017;41:1299\u2013308. https:\/\/doi.org\/10.1097\/PAS.0000000000000838.","journal-title":"Am J Surg Pathol"},{"key":"15870_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/S00428-018-2456-4","volume":"473","author":"H He","year":"2018","unstructured":"He H, Trpkov K, Martinek P, et al. High-grade oncocytic renal tumor: morphologic, immunohistochemical, and molecular genetic study of 14 cases. Virchows Arch. 2018;473:725\u201338. https:\/\/doi.org\/10.1007\/S00428-018-2456-4.","journal-title":"Virchows Arch"},{"key":"15870_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/S00428-023-03700-9","volume":"484","author":"X Zhang","year":"2024","unstructured":"Zhang X, Bolck HA, Rupp NJ, et al. Genomic alterations and diagnosis of renal cancer. Virchows Arch. 2024;484:323\u201337. https:\/\/doi.org\/10.1007\/S00428-023-03700-9.","journal-title":"Virchows Arch"},{"key":"15870_CR10","doi-asserted-by":"publisher","unstructured":"Alaghehbandan R, Montiel DP, Luis AS, et al. Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach. Cancers (Basel). 2019;12. https:\/\/doi.org\/10.3390\/CANCERS12010085.","DOI":"10.3390\/CANCERS12010085"},{"key":"15870_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/J.EURURO.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, et al. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 2022;82:458\u201368. https:\/\/doi.org\/10.1016\/J.EURURO.2022.06.016.","journal-title":"Eur Urol"},{"key":"15870_CR12","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/BIOINFORMATICS\/BTP324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTP324.","journal-title":"Bioinformatics"},{"key":"15870_CR13","doi-asserted-by":"publisher","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinf. 2013;43. https:\/\/doi.org\/10.1002\/0471250953.BI1110S43.","DOI":"10.1002\/0471250953.BI1110S43"},{"key":"15870_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/GR.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356. https:\/\/doi.org\/10.1101\/GR.239244.118.","journal-title":"Genome Res"},{"key":"15870_CR15","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/BIOINFORMATICS\/BTQ170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTQ170.","journal-title":"Bioinformatics"},{"key":"15870_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-; 2016."},{"key":"15870_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/J.HUMPATH.2020.07.003","volume":"104","author":"YJ Liu","year":"2020","unstructured":"Liu YJ, Ussakli C, Antic T, et al. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling. Hum Pathol. 2020;104:18\u201329. https:\/\/doi.org\/10.1016\/J.HUMPATH.2020.07.003.","journal-title":"Hum Pathol"},{"key":"15870_CR18","doi-asserted-by":"publisher","unstructured":"Sanguedolce F, Mazzucchelli R, Falagario UG, et al. Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities. Cancers (Basel). 2024;16. https:\/\/doi.org\/10.3390\/CANCERS16101856.","DOI":"10.3390\/CANCERS16101856"},{"key":"15870_CR19","doi-asserted-by":"publisher","unstructured":"Siadat F, Trpkov K. ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification. Cancers (Basel). 2020;12. https:\/\/doi.org\/10.3390\/CANCERS12010168.","DOI":"10.3390\/CANCERS12010168"},{"key":"15870_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/J.EUF.2017.09.008","volume":"5","author":"J Casuscelli","year":"2019","unstructured":"Casuscelli J, Becerra MF, Manley BJ, et al. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. Eur Urol Focus. 2019;5:642\u20139. https:\/\/doi.org\/10.1016\/J.EUF.2017.09.008.","journal-title":"Eur Urol Focus"},{"key":"15870_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/GCC.20805","volume":"49","author":"J Vieira","year":"2010","unstructured":"Vieira J, Henrique R, Ribeiro FR, et al. Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies. Genes Chromosomes Cancer. 2010;49:935\u201347. https:\/\/doi.org\/10.1002\/GCC.20805.","journal-title":"Genes Chromosomes Cancer"},{"key":"15870_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/CYT.13504","volume":"36","author":"X Zhu","year":"2025","unstructured":"Zhu X, Lei K, Liu X, et al. The Cytopathological Diagnosis of Fumarate Hydratase (FH)-Deficient Renal Cell Carcinoma in Two Patients With FH Gene Mutation. Cytopathology. 2025;36:418\u201322. https:\/\/doi.org\/10.1111\/CYT.13504.","journal-title":"Cytopathology"},{"key":"15870_CR23","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/S41379-022-01057-Z","volume":"35","author":"O Hes","year":"2022","unstructured":"Hes O, Trpkov K. Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities. Mod Pathol. 2022;35:1140\u201350. https:\/\/doi.org\/10.1038\/S41379-022-01057-Z.","journal-title":"Mod Pathol"},{"key":"15870_CR24","doi-asserted-by":"publisher","unstructured":"Pashai Fakhri M, Serth J, Br\u00e4sen JH, et al. Chromophobe renal cell carcinoma - a rare kidney cancer with limited therapy options: a narrative review. BMC Urol. 2025;25. https:\/\/doi.org\/10.1186\/S12894-025-01816-5.","DOI":"10.1186\/S12894-025-01816-5"},{"key":"15870_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/S00292-016-0145-0","volume":"37","author":"C L\u00fcders","year":"2016","unstructured":"L\u00fcders C, Kristiansen G. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?]. Pathologe. 2016;37:153\u20138. https:\/\/doi.org\/10.1007\/S00292-016-0145-0.","journal-title":"Pathologe"},{"key":"15870_CR26","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.5858\/2007-131-1290-IAOCRC","volume":"131","author":"L Liu","year":"2007","unstructured":"Liu L, Qian J, Singh H, et al. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Arch Pathol Lab Med. 2007;131:1290\u20137. https:\/\/doi.org\/10.5858\/2007-131-1290-IAOCRC.","journal-title":"Arch Pathol Lab Med"},{"key":"15870_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAP.0000000000000321","volume":"28","author":"A Hamza","year":"2021","unstructured":"Hamza A, Sirohi D, Smith SC, et al. Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors. Adv Anat Pathol. 2021;28:396\u2013407. https:\/\/doi.org\/10.1097\/PAP.0000000000000321.","journal-title":"Adv Anat Pathol"},{"key":"15870_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.CANCERGEN.2020.04.004","volume":"244","author":"YJ Liu","year":"2020","unstructured":"Liu YJ, Houldsworth J, Emmadi R, et al. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet. 2020;244:40\u201354. https:\/\/doi.org\/10.1016\/J.CANCERGEN.2020.04.004.","journal-title":"Cancer Genet"},{"key":"15870_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002435","author":"QY Xia","year":"2025","unstructured":"Xia QY, Wang XT, Zhang HZ, et al. GPNMB Expression Identifies FLCN-Associated Eosinophilic Renal Tumors With Heterogeneous Clinicopathologic Spectrum and Gene Expression Profiles. Am J Surg Pathol. 2025. https:\/\/doi.org\/10.1097\/PAS.0000000000002435.","journal-title":"Am J Surg Pathol"},{"key":"15870_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.GENE.2017.09.044","volume":"640","author":"LS Schmidt","year":"2018","unstructured":"Schmidt LS, Linehan WM, FLCN. The causative gene for Birt-Hogg-Dub\u00e9 syndrome. Gene. 2018;640:28\u201342. https:\/\/doi.org\/10.1016\/J.GENE.2017.09.044.","journal-title":"Gene"},{"key":"15870_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/J.HUMPATH.2026.106032","author":"B Tekin","year":"2026","unstructured":"Tekin B, Whaley RD, Collins K, et al. Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53\/HPV status in penile squamous cell carcinoma. Hum Pathol. 2026. https:\/\/doi.org\/10.1016\/J.HUMPATH.2026.106032.","journal-title":"Hum Pathol"},{"key":"15870_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/PAS.0000000000002413","volume":"49","author":"P Argani","year":"2025","unstructured":"Argani P, Baraban E, Yaskiv O, et al. Clinically Sporadic Folliculin -mutated Renal Epithelial Neoplasms Represent a Mixture of True Somatic Folliculin -mutated and Occult Birt-Hogg-Dub\u00e9 Syndrome-associated Cases: Morphologic and Molecular Overlap With TSC\/MTOR -mutated Eosinophilic Renal N. Am J Surg Pathol. 2025;49:859\u201372. https:\/\/doi.org\/10.1097\/PAS.0000000000002413.","journal-title":"Am J Surg Pathol"},{"key":"15870_CR33","doi-asserted-by":"publisher","unstructured":"Ramirez Reyes JMJ, Cuesta R, Pause A, Folliculin. A Regulator of Transcription Through AMPK and mTOR Signaling Pathways. Front Cell Dev Biol. 2021;9. https:\/\/doi.org\/10.3389\/FCELL.2021.667311.","DOI":"10.3389\/FCELL.2021.667311"},{"key":"15870_CR34","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1093\/NAR\/GKAE233","volume":"52","author":"A Bakr","year":"2024","unstructured":"Bakr A, Corte G, Della, Veselinov O, et al. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response. Nucleic Acids Res. 2024;52:5698\u2013719. https:\/\/doi.org\/10.1093\/NAR\/GKAE233.","journal-title":"Nucleic Acids Res"},{"key":"15870_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/NATURE09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela I, Tarpey P, Raine K, et al. Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature. 2011;469:539\u201342. https:\/\/doi.org\/10.1038\/NATURE09639.","journal-title":"Nature"},{"key":"15870_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/J.HUMPATH.2014.12.002","volume":"46","author":"JH Park","year":"2015","unstructured":"Park JH, Lee C, Suh JH, et al. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma. Hum Pathol. 2015;46:454\u201360. https:\/\/doi.org\/10.1016\/J.HUMPATH.2014.12.002.","journal-title":"Hum Pathol"},{"key":"15870_CR37","doi-asserted-by":"publisher","unstructured":"Pivovarcikova K, Alaghehbandan R, Vanecek T, et al. TSC\/mTOR Pathway Mutation Associated Eosinophilic\/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background. Biomedicines. 2022;10. https:\/\/doi.org\/10.3390\/BIOMEDICINES10020322.","DOI":"10.3390\/BIOMEDICINES10020322"},{"key":"15870_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/S00428-023-03673-9","volume":"483","author":"C Ricci","year":"2023","unstructured":"Ricci C, Ambrosi F, Franceschini T, et al. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT. Virchows Arch. 2023;483:687\u201398. https:\/\/doi.org\/10.1007\/S00428-023-03673-9.","journal-title":"Virchows Arch"},{"key":"15870_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/J.BBRC.2020.06.133","volume":"530","author":"S Chen","year":"2020","unstructured":"Chen S, Cui L, Hu Q, et al. Preclinical evidence that MNK\/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinoma. Biochem Biophys Res Commun. 2020;530:142\u20138. https:\/\/doi.org\/10.1016\/J.BBRC.2020.06.133.","journal-title":"Biochem Biophys Res Commun"},{"key":"15870_CR40","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/S12094-017-1786-Z","volume":"20","author":"J Cao","year":"2018","unstructured":"Cao J, Sun X, Zhang X, et al. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma. Clin Transl Oncol. 2018;20:761\u20137. https:\/\/doi.org\/10.1007\/S12094-017-1786-Z.","journal-title":"Clin Transl Oncol"},{"key":"15870_CR41","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/J.CELL.2018.03.043","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, et al. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell. 2018;173:595\u2013610. https:\/\/doi.org\/10.1016\/J.CELL.2018.03.043. .e11.","journal-title":"Cell"},{"key":"15870_CR42","doi-asserted-by":"publisher","unstructured":"Alghamdi M, Chen JF, Jungbluth A, et al. L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma. Mod Pathol. 2024;37. https:\/\/doi.org\/10.1016\/J.MODPAT.2024.100467.","DOI":"10.1016\/J.MODPAT.2024.100467"},{"key":"15870_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1101\/GAD.275453.115","volume":"30","author":"T Kantidakis","year":"2016","unstructured":"Kantidakis T, Saponaro M, Mitter R, et al. Mutation of cancer driver MLL2 results in transcription stress and genome instability. Genes Dev. 2016;30:408\u201320. https:\/\/doi.org\/10.1101\/GAD.275453.115.","journal-title":"Genes Dev"},{"key":"15870_CR44","doi-asserted-by":"publisher","first-page":"13131","DOI":"10.3390\/CIMB46110783","volume":"46","author":"S Fan","year":"2024","unstructured":"Fan S, Chen Y, Wang W, et al. Pharmacological and Biological Targeting of FGFR1 in Cancer. Curr Issues Mol Biol. 2024;46:13131\u201350. https:\/\/doi.org\/10.3390\/CIMB46110783.","journal-title":"Curr Issues Mol Biol"},{"key":"15870_CR45","doi-asserted-by":"publisher","first-page":"644","DOI":"10.4103\/JCRT.JCRT_1504_20","volume":"17","author":"X Li","year":"2021","unstructured":"Li X, Guo M, Yang L, et al. BCL6B hypermethylation predicts metastasis and poor prognosis in early-stage hepatocellular carcinoma after thermal ablation. J Cancer Res Ther. 2021;17:644\u201351. https:\/\/doi.org\/10.4103\/JCRT.JCRT_1504_20.","journal-title":"J Cancer Res Ther"},{"key":"15870_CR46","doi-asserted-by":"publisher","unstructured":"Song X, Li M, Wu W, et al. Regulation of BMP2K in AP2M1-mediated EGFR internalization during the development of gallbladder cancer. Signal Transduct Target Ther. 2020;5. https:\/\/doi.org\/10.1038\/S41392-020-00250-3.","DOI":"10.1038\/S41392-020-00250-3"},{"key":"15870_CR47","doi-asserted-by":"publisher","first-page":"15694","DOI":"10.1074\/JBC.M601252200","volume":"281","author":"X Zhang","year":"2006","unstructured":"Zhang X, Ibrahimi OA, Olsen SK, et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem. 2006;281:15694\u2013700. https:\/\/doi.org\/10.1074\/JBC.M601252200.","journal-title":"J Biol Chem"},{"key":"15870_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOM10101399","volume":"10","author":"L Zhuang","year":"2020","unstructured":"Zhuang L, Vogel M, Villiger PM, et al. Dissecting the Interaction of FGF8 with Receptor FGFRL1. Biomolecules. 2020;10:1\u201311. https:\/\/doi.org\/10.3390\/BIOM10101399.","journal-title":"Biomolecules"},{"key":"15870_CR49","doi-asserted-by":"publisher","unstructured":"Nguyen AL, Facey COB, Boman BM. The Complexity and Significance of Fibroblast Growth Factor (FGF) Signaling for FGF-Targeted Cancer Therapies. Cancers (Basel). 2024;17. https:\/\/doi.org\/10.3390\/CANCERS17010082.","DOI":"10.3390\/CANCERS17010082"},{"key":"15870_CR50","doi-asserted-by":"publisher","unstructured":"Amaral BS, Macek P, Arora A, et al., et al. Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses. Curr Urol Rep. 2021;22. https:\/\/doi.org\/10.1007\/S11934-021-01064-8.","DOI":"10.1007\/S11934-021-01064-8"},{"key":"15870_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/1947601909359929","volume":"1","author":"AR Brannon","year":"2010","unstructured":"Brannon AR, Reddy A, Seiler M, et al. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes Cancer. 2010;1:152\u201363. https:\/\/doi.org\/10.1177\/1947601909359929.","journal-title":"Genes Cancer"},{"key":"15870_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/J.EURURO.2015.04.004","volume":"68","author":"PO Richard","year":"2015","unstructured":"Richard PO, Jewett MAS, Bhatt JR, et al. Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience. Eur Urol. 2015;68:1007\u201313. https:\/\/doi.org\/10.1016\/J.EURURO.2015.04.004.","journal-title":"Eur Urol"},{"key":"15870_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/PAS.0000000000002215","volume":"48","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhang X, Xia Q, et al. Clinicopathologic and Molecular Characterization of Xanthomatous Giant Cell Renal Cell Carcinomas: Further Support for a Close Morphologic Spectrum to Eosinophilic Solid and Cystic Renal Cell Carcinomas. Am J Surg Pathol. 2024;48:662\u201370. https:\/\/doi.org\/10.1097\/PAS.0000000000002215.","journal-title":"Am J Surg Pathol"},{"key":"15870_CR54","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/J.EURURO.2020.03.003","volume":"78","author":"SL Skala","year":"2020","unstructured":"Skala SL, Wang X, Zhang Y, et al. Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms. Eur Urol. 2020;78:63\u201374. https:\/\/doi.org\/10.1016\/J.EURURO.2020.03.003.","journal-title":"Eur Urol"},{"key":"15870_CR55","doi-asserted-by":"publisher","DOI":"10.1159\/000545946","author":"L Lanteri","year":"2025","unstructured":"Lanteri L, Luppi E, Cimadamore A, et al. Oncocytic Tumors in the Kidney: A Tri-Focal Review - Integrated Pathological, Cytopathological, and Molecular Perspectives, Part 2. Acta Cytol. 2025. https:\/\/doi.org\/10.1159\/000545946.","journal-title":"Acta Cytol"},{"key":"15870_CR56","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/HIS.13865","volume":"75","author":"K Trpkov","year":"2019","unstructured":"Trpkov K, Williamson SR, Gao Y, et al. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity? Histopathology. 2019;75:174\u201384. https:\/\/doi.org\/10.1111\/HIS.13865.","journal-title":"Histopathology"},{"key":"15870_CR57","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/S41587-021-00994-5","volume":"39","author":"W Xiao","year":"2021","unstructured":"Xiao W, Ren L, Chen Z, et al. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nat Biotechnol. 2021;39:1141\u201350. https:\/\/doi.org\/10.1038\/S41587-021-00994-5.","journal-title":"Nat Biotechnol"},{"key":"15870_CR58","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/NAR\/GKAB951","volume":"50","author":"Y Xue","year":"2022","unstructured":"Xue Y, Bao Y, Zhang Z, et al. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 2022;50:D27\u201338. https:\/\/doi.org\/10.1093\/NAR\/GKAB951.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15870-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15870-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15870-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:50:40Z","timestamp":1777863040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15870-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15870"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15870-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was in compliance with the Declaration of Helsinki and was approved by the Ethics Committee of National Cancer Center \/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Ethics Approval No: 23\/095-3843). The requirement of informed written consent to the participates was waived by the Ethics Committee of National Cancer Center \/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. The study was conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Jie Zuo, Tieliang Pang, Zhiyi Zhang are employees of Biotecnovo (Beijing) Co. Ltd. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"563"}}